Get Wall Street analysts ratings for Pfizer Inc. (PFE). Buy or Sell this stock? See what the analysts say Stock Upgrades & Downgrades · Editors' Picks · Quick. PFE | Complete Pfizer Inc. stock news by MarketWatch. View real Novartis upgrade, Intel downgrade part of Erste global equity changes. Sep. 5. Pfizer (PFE) Ascends While Market Falls: Some Facts to Note. In the most recent trading session, Pfizer (PFE) closed at $, indicating a +% shift from. PFE is currently covered by 18 analysts with an average price target of $ This is a potential upside of $ (%) from yesterday's end of day. Latest PFE news ; pm ET Arbutus Biopharma price target raised to $7 from $5 at Jefferies ; am ET Novartis upgrade, Intel downgrade part of Erste global.
If your stock certificate is lost, stolen, or destroyed, notify Computershare immediately at () They will place a "stop transfer" on the. The average stock forecast for Pfizer Inc (PFE) in the next 12 months is USD. This price target corresponds to an upside of %. The range of stock. See Pfizer Inc. (PFE) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Oct, Upgrade, Jefferies ; Jul, Reiterated, JP Morgan ; Jul, Initiated, HSBC Securities ; Jun, Downgrade, Credit Suisse. Pfizer Expects Adjusted EPS Of $$2. Benzinga Newsdesk - Jul 30, , AM · Pfizer shares are trading higher. The latest public price target was made on Aug 7, by Narumi Nakagiri from Daiwa, who expects PFE stock to rise by 17% over the next 12 months. Pfizer Inc. analyst ratings, historical stock prices, earnings estimates & actuals. PFE updated stock price target summary. Pfizer Inc's current ratio is less than Historically, companies with strong liquidity have a current ratio above 2. Upgrade to DiscoverCI Pro to get. Pfizer stock upgraded from Sell Candidate to Hold/Accumulate after Wednesday trading session. (Updated on Sep 04, ) The Pfizer stock price gained %. The 13 analysts with month price forecasts for Pfizer stock have an average target of , with a low estimate of 29 and a high estimate of Trading Signals. New Recommendations; Top Stocks to Own; Top Signal Strength; Top Signal Direction; Stock Signal Upgrades. Sectors. Stock Market Sectors; Major.
Content From Our Affiliates · Arbutus Biopharma price target raised to $7 from $5 at Jefferies 5 Hours Ago TipRanks · Novartis upgrade, Intel downgrade part of. According to analysts, Pfizer's stock has a predicted upside of % based on their month stock forecasts. Has Pfizer been upgraded by Wall Street analysts. Stock PFE PFIZER, INC. PDF Report. Consensus Pfizer, Inc. Equities. PFE upgrading estimates Number of unchanged estimates Number of downgrading. You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how PFE scored across 38 valuation, financial, forecast, performance, and dividend. The average one-year price target for Pfizer Inc. is $ The forecasts range from a low of $ to a high of $ A stock's price target is the price. Oct, Upgrade, Jefferies ; Jul, Reiterated, JP Morgan ; Jul, Initiated, HSBC Securities ; Jun, Downgrade, Credit Suisse. Stock Price Targets. High, $ Median, $ Low, $ Average, $ Current Price, $ Yearly Numbers. Estimates. PFE will report earnings. Analyst Ratings of PFIZER INC(NYSE:PFE) stock. Analyst ratings, forecast, price target, upgrades and downgrades. Pfizer stock is trading below its day moving average, but remains above its day line. The stock broke out of a flat base with a buy point at on.
Pfizer (NYSE: PFE). $ (%). $ Price as of September 4, Pfizer Inc. research and ratings by Barron's. View PFE revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. PFE Stock Overview · Trading at % below our estimate of its fair value · Earnings are forecast to grow 35% per year · Trading at good value compared to peers. Analyst Forecast. According to 14 analysts, the average rating for PFE stock is "Buy." The month stock price forecast is $, which is an increase of. See PFE stock price and Buy/Sell Pfizer. Discuss news and analysts' price predictions with the investor community.
Pfizer surprises with Q4 profit as primary-care sales offset covid slump. Pfizer is sticking to its prior profit forecasts but sees a potential boost from. Upgrade to Premium to access your Watchlist and more. Upgrade Now · Or Login to Your Premium Account. PFIZER INC. Stock (NYSE). PFE. Payout Change. Pending.